STOCK TITAN
  1. Home
  2. News
  3. ZBH

Zimmer Biomet Holdings, Inc. - ZBH STOCK NEWS

Welcome to our dedicated page for Zimmer Biomet Holdings news (Ticker: ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet Holdings stock.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) is a preeminent global leader in musculoskeletal healthcare. Headquartered in Warsaw, Indiana, Zimmer Biomet has been at the forefront of advancing bone and joint health for nearly 90 years. The company designs, manufactures, and markets a comprehensive range of orthopedic implants and surgical equipment, addressing joint reconstruction, bone repair, sports medicine, spine, and dental reconstruction. Its innovative product portfolio includes the ROSA® Robotics systems for knee, hip, and shoulder replacements, and the TMINI Miniature Robotic System for total knee arthroplasty.

Zimmer Biomet's latest endeavors include the establishment of a dedicated Health Equity division in 2023, which aims to integrate health equity into the company's core strategies and operations. This division has already made significant strides by assembling a strategic advisory board and developing the Community Centered Care (C3) framework to increase patient access to quality care in underserved communities.

In addition, Zimmer Biomet has recently partnered with top pickleball organizations in the U.S., underscoring its commitment to joint health and well-being for the growing community of pickleball players. The company also announced a strategic alliance with CBRE Group, Inc. to expand orthopedic ambulatory surgery centers across the country, and a collaboration with RevelAi Health to commercialize AI-powered engagement solutions aimed at advancing value-based orthopedic care and health equity.

Financially, Zimmer Biomet has demonstrated robust performance, with first-quarter 2024 net sales amounting to $1.889 billion, a 3.2% year-over-year increase. The company continues to focus on innovation, operational excellence, and strategic partnerships to drive growth and enhance shareholder value. For more information, visit www.zimmerbiomet.com or follow them on LinkedIn and Twitter.

News

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (ZBH) declares a quarterly cash dividend of $0.24 per share for the first quarter of 2024, approved by the Board of Directors. This move reflects the company's commitment to rewarding its stockholders and maintaining financial stability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
dividends
-
News

Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. signs the Zero Health Gaps Pledge to address health disparities by integrating health equity into its core strategies. The newly established Health Equity division focuses on reducing healthcare inequities, tracking progress, and collaborating on community-based solutions. The division aims to increase patient access to quality care in underserved communities through a Community Centered Care framework and partnerships with healthcare institutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
none
-
News

Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting

Rhea-AI Summary
Zimmer Biomet showcases innovative products at AAOS meeting, featuring ROSA Robotics for pending 510(k) clearance, Persona OsseoTi Keel Tibia, and HAMMR Automatic Hip Impaction System. The company highlights its commitment to transformative clinical care and customer-centric solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
none
News

Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. reported a 6.3% increase in net sales for the fourth quarter and a 6.5% increase for the full year. Full-year diluted earnings per share were $4.88, and adjusted diluted earnings per share were $7.55. The company provided full-year 2024 financial guidance with projected revenue change of 4.5% - 5.5% and adjusted diluted EPS of $8.00 - $8.15.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.54%
Tags
earnings
-
News

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2023 Financial Results

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (ZBH) has announced its fourth quarter earnings conference call and webcast on February 8, 2024. The live audio webcast will be accessible via the company's Investor Relations website. Additionally, an in-person product showcase event for investors and analysts will be held on February 13, 2024, at the American Academy of Orthopaedic Surgeons Conference in San Francisco.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
earnings
-
News

Zimmer Biomet Announces Appointment of Louis A. Shapiro to Board of Directors

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) appoints Louis A. Shapiro, former President and CEO of Hospital for Special Surgery, to the Board, leveraging his extensive industry leadership experience and customer perspective.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
management
News

Zimmer Biomet to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
conferences
-
News

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2023

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) approves $0.24 per share cash dividend for Q4 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
dividends
-
News

Zimmer Biomet to Present at the 2023 Piper Sandler Healthcare Conference

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) to Present at 2023 Piper Sandler Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
conferences
News

Zimmer Biomet Announces Third Quarter 2023 Financial Results

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. reported a 5.0% increase in net sales for Q3 2023, reaching $1.754 billion, with diluted earnings per share of $0.77 and adjusted diluted earnings per share of $1.65. The company updated its 2023 reported revenue guidance due to currency expectations and reaffirmed 2023 constant currency revenue growth and adjusted earnings per share financial guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
earnings

FAQ

What is the current stock price of Zimmer Biomet Holdings (ZBH)?

The current stock price of Zimmer Biomet Holdings (ZBH) is $107.12 as of December 20, 2024.

What is the market cap of Zimmer Biomet Holdings (ZBH)?

The market cap of Zimmer Biomet Holdings (ZBH) is approximately 21.2B.

What does Zimmer Biomet do?

Zimmer Biomet designs, manufactures, and markets orthopedic implants and surgical equipment, focusing on joint reconstruction, bone repair, sports medicine, spine, and dental reconstruction.

Where is Zimmer Biomet headquartered?

Zimmer Biomet is headquartered in Warsaw, Indiana, USA.

What are Zimmer Biomet's latest innovations?

Zimmer Biomet's latest innovations include the ROSA® Robotics systems for knee, hip, and shoulder replacements, and the TMINI Miniature Robotic System for total knee arthroplasty.

What is Zimmer Biomet's focus on health equity?

Zimmer Biomet established a Health Equity division in 2023 to integrate health equity into its core strategies and operations, aiming to reduce healthcare disparities and improve access to quality care in underserved communities.

How did Zimmer Biomet perform financially in the first quarter of 2024?

Zimmer Biomet reported first quarter net sales of $1.889 billion in 2024, marking a 3.2% increase from the prior year period.

What are Zimmer Biomet's partnerships?

Zimmer Biomet has partnerships with top pickleball organizations, CBRE Group, Inc. for orthopedic ambulatory surgery centers, and RevelAi Health for AI-powered engagement solutions.

What is the ROSA® Robotics system?

The ROSA® Robotics system is a suite of robotic equipment designed to assist in knee, hip, and shoulder replacement surgeries, enhancing precision and patient outcomes.

What is the Community Centered Care (C3) framework?

The C3 framework is part of Zimmer Biomet's Health Equity division, focused on increasing patient access to quality care in underserved communities by aligning the interests of surgeons, hospitals, payors, and the community.

What is Zimmer Biomet's role in pickleball?

Zimmer Biomet has partnered with key pickleball organizations in the U.S. to support joint health and well-being for the growing community of players and raise awareness about the importance of healthy bodies.

How does Zimmer Biomet contribute to innovation in healthcare?

Zimmer Biomet continuously innovates through its comprehensive product portfolio, strategic partnerships, and integration of advanced technologies like AI and robotics to enhance patient care and outcomes.

Stock ZBH logo
Zimmer Biomet Holdings, Inc.

NYSE:ZBH

ZBH Rankings

#516 Ranked by Market Cap
#1867 Ranked by Dividends

ZBH Stock Data

21.17B
198.78M
0.14%
93.29%
3.45%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
WARSAW